News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Precious1GPT: Multimodal Transfer Learning for Aging Clock Development and Target Discovery

Aging

June 20, 2023
PRESS RELEASE: A new research paper was published in Aging's Volume 15, Issue 11, entitled, “Precious1GPT: multimodal transformer-based transfer learning for aging clock development and feature importance analysis for aging and age-related disease target discovery.” continue reading »

Metformin’s Role in Preventing Metabolic Syndrome during Androgen Deprivation Therapy: A Phase II Study

News

June 20, 2023
PRESS RELEASE: On June 19, 2023, a new research paper was published in Oncotarget, entitled, “Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer.” continue reading »

Impact Journals Sponsors 2023 Ride for Roswell

News

June 19, 2023
Impact Journals is sponsoring Team Open Access in the annual cycling event to end cancer: The Ride for Roswell. continue reading »

Short Telomeres in Alveolar Type II Cells Associate With Lung Fibrosis in Post COVID-19 Patients With Cancer

Aging

June 15, 2023
PRESS RELEASE: A new research paper was published on the cover of Aging's Volume 15, Issue 11, entitled, “Short telomeres in alveolar type II cells associate with lung fibrosis in post COVID-19 patients with cancer.” continue reading »

ACSL4: Biomarker, Mediator and Target in Quadruple Negative Breast Cancer

News

June 14, 2023
PRESS RELEASE: On June 12, 2023, a new review paper was published in Oncotarget, entitled, “ACSL4: biomarker, mediator and target in quadruple negative breast cancer.” continue reading »